Test AI and MRI scores to spot prostate cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older and not over 80
- You have signs that suggest prostate cancer and are getting your first biopsy series, or new biopsies after prior negative biopsies
- Your PSA blood test result is 30 ng/mL or lower
- Your exam suggests the cancer is not beyond stage T2c (not T3 or T4)
- Your prostate MRI is done within 3 months before the biopsy, on the study’s approved MRI machines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether taking extra biopsy samples from specific areas seen on an MRI can better detect prostate cancer compared to the standard method of taking samples from all over the prostate. It may help men who have a suspicious MRI finding and a higher PSA level.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.